Medtronic plc (MDT)
| Market Cap | 118.79B |
| Revenue (ttm) | 34.20B |
| Net Income (ttm) | 4.66B |
| Shares Out | 1.28B |
| EPS (ttm) | 3.62 |
| PE Ratio | 25.61 |
| Forward PE | 16.19 |
| Dividend | $2.84 (3.06%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 4,875,791 |
| Open | 91.68 |
| Previous Close | 91.10 |
| Day's Range | 91.68 - 92.96 |
| 52-Week Range | 79.29 - 96.25 |
| Beta | 0.82 |
| Analysts | Buy |
| Price Target | 101.58 (+9.57%) |
| Earnings Date | Aug 19, 2025 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $101.58, which is an increase of 9.57% from the latest price.
News
Medtronic makes two key additions to its board. How activist Elliott can build shareholder value
The stage seems to be set for a long-term mutually beneficial relationship between the parties.
Medtronic: Earnings Are Solid, New Board Additions Add Intrigue
Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involve...
Medtronic Has Potential To Pursue Further Divestitures: Analyst
On Tuesday, Medtronic Plc MDT reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.
These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings
Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effect...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday.
Activist investor Elliott push spurs changes at Medtronic
Medical device maker Medtronic is making changes to its board after Elliott Investment Management became one of its largest shareholders. CNBC's David Faber breaks down the details.
Medtronic plc (MDT) Q1 2026 Earnings Call Transcript
Medtronic plc (NYSE:MDT) Q1 2026 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Geoffrey Straub Martha - Chairman of the Board & CEO Michael Marinaro - Executive VP & Presid...
Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway.
Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.
Medtronic raises annual profit forecast on lower tariff impact
Medical-device maker Medtronic raised its fiscal 2026 profit forecast on Tuesday and said it expects a smaller-than-expected impact from the tariffs proposed by U.S. President Donald Trump.
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfo...
Medtronic reports first quarter fiscal 2026 financial results
11th quarter in a row of mid-single digit organic revenue growth; Poised to accelerate growth GALWAY, Ireland , Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare t...
Medtronic to add directors, form committees after Elliott takes large stake, WSJ reports
Medtronic will add two new directors and form new committees, after Elliott Investment Management became one of its largest shareholders, the Wall Street Journal reported on Tuesday, citing people fam...
Medtronic to Add Directors After Elliott Becomes Big Shareholder
The medical-device maker also plans to form committees focused on M&A and other growth areas.
Buy or Sell Medtronic Stock Now?
Medtronic (NYSE:MDT) will report earnings on Tuesday, August 19, 2025. Over the last five years, the stock's next-day move following results has been highly unpredictable: it posted a positive one-day...
Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Medtronic plc MDT will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.
Medtronic announces cash dividend for second quarter of fiscal year 2026
GALWAY, Ireland , Aug. 14, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal y...
Former Medtronic Supply Chain Leader Joins FourKites' Strategic Advisory Council
CHICAGO--(BUSINESS WIRE)--FourKites®, the global leader in AI-driven supply chain transformation, today announced that Dov Shenkman, CEO and Founding Member of Atid Group LLC, has joined its Strategic...
Medtronic to announce financial results for its first quarter of fiscal year 2026
GALWAY, Ireland , Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, f...
More Downside For Medtronic Stock?
Medtronic (NYSE:MDT), which is renowned for inventing the world's first battery-operated implantable pacemaker, has over time earned respect as a worldwide leader in medical technology and has created...
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to i...
Medtronic: Growth Challenges Persist
Medtronic's decade-long underperformance stems from stagnant revenue growth, declining margins, and inconsistent returns on invested capital, despite a solid dividend history. The Diabetes segment spi...
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
GALWAY, Ireland , July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the...